HALO logo
halo search icon
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
COGT · NAS

Cogent Biosciences, Inc.

US$32.92

Price Arrow1.67 (5.36%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusExtreme OversoldHALO AllNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cogent Biosciences, Inc. Overview

COGT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About COGT

icon

Telephone

1.617.945.5576

icon

Address

3rd floor, 275 Wyman Street, Waltham, MA 02451

Description

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

COGT Price Chart

Key Stats

Market Cap

US$5.34B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.75 - 43.73

Trade Value (12mth)

US$15,418,542.00

1 week

-4.38%

1 month

-14.92%

YTD

-10.05%

1 year

527.51%

All time high

70.64

Key Fundamentals

EPS 3 yr Growth

6.80%

EBITDA Margin

0.00%

Operating Cashflow

-$264m

Free Cash Flow Return

-46.20%

ROIC

-57.40%

Interest Coverage

-107.40

Quick Ratio

14.20

Other Data

Shares Outstanding (Fully Diluted)

162m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

COGT Announcements

Latest Announcements

DateAnnouncements
05 May 26
05 May 26
05 May 26
05 May 26
18 February 26

COGT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.42-2.46-2.55locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.42-2.46-2.55locklocklock
Growth
%locklocklocklock-1.2-1.9-3.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cogent Biosciences, Inc. (COGT:NAS)?
Halo FAQ
The current share price of Cogent Biosciences, Inc. (COGT:NAS) is USD$32.92.
What is the 52-week high share price for Cogent Biosciences, Inc. (COGT:NAS)?
Halo FAQ
The 52-week high share price for Cogent Biosciences, Inc. (COGT:NAS) is USD$43.73.
What is the 52-week low share price for Cogent Biosciences, Inc. (COGT:NAS)?
Halo FAQ
The 52-week low share price for Cogent Biosciences, Inc. (COGT:NAS) is USD$4.75.
What is the dividend yield for Cogent Biosciences, Inc. (COGT:NAS)?
Halo FAQ
Cogent Biosciences, Inc. (COGT:NAS) does not pay a dividend.
What was Cogent Biosciences, Inc. (COGT:NAS) last dividend payment?
Halo FAQ
Cogent Biosciences, Inc. (COGT:NAS) does not pay a dividend.
What is the franking level for Cogent Biosciences, Inc. (COGT:NAS)?
Halo FAQ
Cogent Biosciences, Inc. (COGT:NAS) has a franking level of 0.00%.
In which sector is Cogent Biosciences, Inc. (COGT:NAS) classified?
Halo FAQ
Cogent Biosciences, Inc. (COGT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.